1 / 10

PGEU Symposium

PGEU Symposium. 15 June 2004 Contribution to the Panel discussion Claudio Lepori Member of the AESGP Board AESGP Offices : 7, Avenue de Tervuren, B-1040 Brussels Tel: +32 2 735 51 30, Fax: +32 2 735 52 22, info@aesgp.be. New study. THE ECONOMIC. AND PUBLIC HEALTH VALUE.

corin
Download Presentation

PGEU Symposium

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PGEU Symposium 15 June 2004 Contribution to the Panel discussion Claudio Lepori Member of the AESGP Board AESGP Offices : 7, Avenue de Tervuren, B-1040 Brussels Tel: +32 2 735 51 30, Fax: +32 2 735 52 22, info@aesgp.be

  2. New study THE ECONOMIC AND PUBLIC HEALTH VALUE OF SELF-MEDICATION

  3. Analysis of the benefits of self-medication based on an economic model • The study demonstratesthe evidence base of the economic value of self-medicationand theincremental benefits of an increase in the levels of self-medication • The study shows that total annual savings will exceed 16 billion euros in the enlarged Europe. • Based on an economic model,the study analyses the economic and financial impact derived from a shift of 5% of prescribed products to self-medication • On the basis that, as wide research has shown: - There is asubstitution effectbetween prescribed medications and self-medication - Around15% of all prescriptions are related to the treatment of minor illnesses

  4. Analysis of the benefits of self-medicationType of impact and affected party Table 1 shows the relevant factors affecting costs and the main parties involved

  5. Analysis of the benefits of self-medicationAnnual savings in an enlarged Europe

  6. Analysis of the benefits of self-medicationillness seen versus costs incurred Encouraging a shift to self-care would have the effect of transferring costs through each level

  7. Rx-to-OTC switching and new medications for self-medication. Impact on public health • Self-medication also contributes effectively to public health • Through the analysis of three indication areas: smoking cessation, vaginal mycosis and heart disease prevention, the study demonstrates how responsible self-medication has a positive health outcome for the individual and additional positive consequences for the society as a whole • The availability of innovative non-prescription medicines: has the potential of increasing the likelihood of treatment and by that of reducing the number of sufferers • Increasing the evidence that a shift of medicines from prescription to non-prescription status and the availability of a growing range of non-prescription medicines will make an important contribution to public health

  8. New medications for self-medication. Impact on public health Possible future new indications suitable for self-treatment, in the frame of collaborative care, can make an increasing contribution to improve public health

  9. Policy recommendations • In order to make concrete progress with regard to an appropriate self-medication policy, the study suggests, following the G10 recommendations, a number of measures: • Increasing education and information on self-care options • Better communication on non-prescription medicines • Efficient marketing authorisation procedures • Speedy and transparent mechanisms to change product classification status • Free pricing for self-medication products

  10. THE ECONOMIC AND PUBLIC HEALTH VALUE OF SELF-MEDICATION

More Related